Import Alert 55-03: DETENTION WITHOUT PHYSICAL EXAMINATION OF DIFFERENT FORMS OF HEPARIN AND HEPARIN-RELATED PRODUCTS

55-03: DETENTION WITHOUT PHYSICAL EXAMINATION OF DIFFERENT FORMS OF HEPARIN AND HEPARIN-RELATED PRODUCTS. Dated 685 days ago, it serves as a historical benchmark. Score 35/100. As of 2026-11-03, from U.S. FDA Import Alerts (accessdata.fda.gov).

Data as of · Compiled by Zalwin from U.S. FDA Import Alerts (accessdata.fda.gov)

Free preview: all 5 published fields of this record are shown below. Locked: 17 related FdaImportAlertPulse records and the 5-column CSV export.

FieldValue
Alert number55-03
NameDETENTION WITHOUT PHYSICAL EXAMINATION OF DIFFERENT FORMS OF HEPARIN AND HEPARIN-RELATED PRODUCTS
IndustryDrugs & biologics
TypeDWPE
Last published2024-12-19
Peer records CSV (18 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch 55-03

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock 55-03 + all 18 records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Alert · Name · Industry · Type · Last published · official source URL

  • Source agency: U.S. FDA Import Alerts (accessdata.fda.gov)
  • Record date: 2024-12-19
  • Data refreshed: 2026-11-03
  • Refunds on request within 14 days

Search all records free →

Browse FdaImportAlertPulse by state and category →

LIVE PUBLIC DATA Source: U.S. FDA Import Alerts (accessdata.fda.gov) · Last refreshed: Tue, 03 Nov 2026 19:38:30 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Peer benchmark and outreach value: 55-03 and 18 drugs peers

  • drugs FdaImportAlertPulse records like this one: 18
  • Timing: Low: older than 30 days
  • Estimated pipeline if you contact every drugs peer: $3,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)

Search, filter and export more FdaImportAlertPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

35 / 100 Compliance Urgency Score

  • Detention without physical examination.

What is the FdaImportAlertPulse record for 55-03?

FDA Import Alert 55-03 (DWPE, Drugs & biologics) was last published 2024-12-19: DETENTION WITHOUT PHYSICAL EXAMINATION OF DIFFERENT FORMS OF HEPARIN AND HEPARIN-RELATED PRODUCTS.

How does 55-03 compare to other FdaImportAlertPulse records?

It is 685 days old; check the official source for later updates before acting. Its Compliance Urgency Score of 35/100 is modest; treat it as background rather than a priority.

55-03 vs. top 3 peers

OrganizationLocationRecord date
55-03drugs2024-12-19
66-41drugs2026-11-02
66-40drugs2026-10-27
66-72drugs2026-10-15

Related records

FdaImportAlertPulse: Drugs & biologics FdaImportAlertPulse: DWPE

How to monitor 55-03 and peer dwpe records

Get new FdaImportAlertPulse records like 55-03 by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get import alert updates for your categories

FdaImportAlertPulse emails when an import alert in your industry is published or updated.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From FDA's published import alert list; the FDA alert page (linked) is authoritative and lists the firms and products covered. Informational only, not regulatory advice.

Often used together